BTIG Reiterates Buy Rating on Apogee Therapeutics with PT Raised to $137.

lunes, 23 de marzo de 2026, 11:34 am ET1 min de lectura
APGE--

BTIG Reiterates Buy Rating on Apogee Therapeutics with PT Raised to $137.

BTIG Reiterates Buy Rating on Apogee Therapeutics with PT Raised to $137.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios